Literature DB >> 26393101

Pattern of primary tuberculosis drug resistance and associated treatment outcomes in Transnistria, Moldova.

O Dolgusev1, N Obevzenco2, O Padalco3, S Pankrushev4, A Ramsay5, R Van den Bergh6, M Manzi6, O Denisiuk7, R Zachariah6.   

Abstract

This cohort study assessed drug susceptibility testing (DST) patterns and associated treatment outcomes from Transnistria, Moldova, from 2009 to 2012. Of 1089 newly registered tuberculosis (TB) patients with available DST results, 556 (51%) had some form of drug resistance, while 369 (34%) had multidrug-resistant TB (MDR-TB). There were four cases of extensively drug-resistant TB. MDR-TB patients had poor treatment success (45%); human immunodeficiency virus positivity and a history of incarceration were associated with an unfavourable treatment outcome. This first study from Trans-nistria shows a high level of drug-resistant TB, which constitutes a major public health problem requiring urgent attention.

Entities:  

Keywords:  SORT IT; incarceration; migration; operational research

Year:  2014        PMID: 26393101      PMCID: PMC4547515          DOI: 10.5588/pha.14.0043

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  4 in total

1.  Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.

Authors:  Neel R Gandhi; Paul Nunn; Keertan Dheda; H Simon Schaaf; Matteo Zignol; Dick van Soolingen; Paul Jensen; Jaime Bayona
Journal:  Lancet       Date:  2010-05-22       Impact factor: 79.321

2.  Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions.

Authors:  W M Jakubowiak; E M Bogorodskaya; S E Borisov; E S Borisov; I D Danilova; D I Danilova; E V Kourbatova; E K Kourbatova
Journal:  Int J Tuberc Lung Dis       Date:  2007-01       Impact factor: 2.373

3.  Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-resistant Tuberculosis in the WHO European Region 2011-2015: Cost-effectiveness analysis.

Authors:  Zsuzsanna Jakab; Colleen D Acosta; Hans H Kluge; Masoud Dara
Journal:  Tuberculosis (Edinb)       Date:  2015-03-06       Impact factor: 3.131

4.  Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.

Authors:  Shama D Ahuja; David Ashkin; Monika Avendano; Rita Banerjee; Melissa Bauer; Jamie N Bayona; Mercedes C Becerra; Andrea Benedetti; Marcos Burgos; Rosella Centis; Eward D Chan; Chen-Yuan Chiang; Helen Cox; Lia D'Ambrosio; Kathy DeRiemer; Nguyen Huy Dung; Donald Enarson; Dennis Falzon; Katherine Flanagan; Jennifer Flood; Maria L Garcia-Garcia; Neel Gandhi; Reuben M Granich; Maria G Hollm-Delgado; Timothy H Holtz; Michael D Iseman; Leah G Jarlsberg; Salmaan Keshavjee; Hye-Ryoun Kim; Won-Jung Koh; Joey Lancaster; Christophe Lange; Wiel C M de Lange; Vaira Leimane; Chi Chiu Leung; Jiehui Li; Dick Menzies; Giovanni B Migliori; Sergey P Mishustin; Carole D Mitnick; Masa Narita; Philly O'Riordan; Madhukar Pai; Domingo Palmero; Seung-kyu Park; Geoffrey Pasvol; Jose Peña; Carlos Pérez-Guzmán; Maria I D Quelapio; Alfredo Ponce-de-Leon; Vija Riekstina; Jerome Robert; Sarah Royce; H Simon Schaaf; Kwonjune J Seung; Lena Shah; Tae Sun Shim; Sonya S Shin; Yuji Shiraishi; José Sifuentes-Osornio; Giovanni Sotgiu; Matthew J Strand; Payam Tabarsi; Thelma E Tupasi; Robert van Altena; Martie Van der Walt; Tjip S Van der Werf; Mario H Vargas; Pirett Viiklepp; Janice Westenhouse; Wing Wai Yew; Jae-Joon Yim
Journal:  PLoS Med       Date:  2012-08-28       Impact factor: 11.069

  4 in total
  3 in total

1.  The scourge of tuberculosis and anti-tuberculosis drug resistance in Eastern Europe.

Authors:  Helen Cox; Nathan Ford
Journal:  Public Health Action       Date:  2014-10-21

2.  Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.

Authors:  Omowunmi Aibana; Mariya Bachmaha; Viatcheslav Krasiuk; Natasha Rybak; Timothy P Flanigan; Vasyl Petrenko; Megan B Murray
Journal:  BMC Infect Dis       Date:  2017-02-07       Impact factor: 3.090

3.  Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis.

Authors:  Joel Philip Samuels; Aashna Sood; Jonathon R Campbell; Faiz Ahmad Khan; James Cameron Johnston
Journal:  Sci Rep       Date:  2018-03-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.